Core Viewpoint - Hengan International (01044) reported a revenue increase of 1.8% year-on-year for the fiscal year ending December 31, 2025, driven by growth in tissue sales, despite a decline in hygiene product sales and increased promotional expenses [1] Financial Performance - The company achieved a total revenue of 23.069 billion RMB for the fiscal year, with a profit attributable to equity holders of 2.535 billion RMB, reflecting a year-on-year increase of 10.3% [1] - The overall gross profit for 2025 rose approximately 6.6% to around 7.806 billion RMB, supported by effective tissue sales growth [1] Dividend Announcement - Hengan International proposed a final dividend of 0.7 RMB per share [1] Margin Improvement - The gross margin improved to approximately 33.8% for the year, attributed to reduced promotional spending on tissue products and a recovery in hygiene product sales in the second half of 2025 [1]
恒安国际午后涨超4% 去年纯利同比增一成 毛利率改善至约33.8%